NCI partners with CrossChx

NCI, Inc., a provider of advanced information technology (IT) solutions and professional services to US Federal Government agencies, has announced that it has entered into an exclusive partnership with Columbus, Ohio-based CrossChx, Inc., the company said.

Under the partnership, CrossChx will work with NCI to bring its artificial intelligence (AI) commercial capabilities to government customers, enhancing NCI´s quality of premier solutions while simultaneously creating new opportunities for NCI employees.

NCI´s AI capabilities will be unique in the market through a focus on scaling humans, an AI approach that uses continual machine learning and automated processes to build greater workforce and organizational results. Through this partnership, NCI intends to explore opportunities to improve the efficiency of its current operations, providing true interoperability and collaboration between customers, employees and AI systems.

NCI launched seven pilots in August 2017, utilizing the CrossChx AI platform to provide proof of concepts across areas such as fraud, waste and abuse, cybersecurity, machine-to-machine communication (M2M) and patient care coordination. NCI plans to deploy these capabilities in several customer environments beginning in 2018 and will have a patient care demonstration available at the HIMSS18 Conference and Exhibition in Las Vegas from March 5-9, 2018.

NCI is a provider of enterprise solutions and services to US defense, intelligence, health and civilian government agencies. The company has the expertise and proven track record to solve its customers´ most important and complex mission challenges through technology and innovation.

Founded in 2012, CrossChx is building operational artificial intelligence, which empowers humans to achieve more than ever before. Olive, the company´s AI solution, acts as the intelligent router between systems and data by automating repetitive, high volume tasks and workflows providing true interoperability for organizations. For more information, visit www.hireolive.com.